Concepedia

Rumi Kawabata

RK

4

Publications

90

Citations

4

H-Index

2011

Active since

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Rumi Kawabata is an author at Taiho Pharmaceutical (Japan) specializing in tumor microenvironment, cell biology, and oncology.

Top concepts

Publications per year

2011–2020

4

Publications

4

Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728

Hiroki Irie, Rumi Kawabata, Yayoi Fujioka et al. · Cancer Science · 2020 · 37 citations · Full text

, , +20

Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways

Hiromi Muraoka, Chihoko Yoshimura, Rumi Kawabata et al. · Cancer Science · 2019 · 24 citations · Full text

Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines

Rumi Kawabata · International Journal of Oncology · 2011 · 19 citations · Full text

, , +12

Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells

Kentaro Wakasa, Rumi Kawabata, Seiki Nakao et al. · PLoS ONE · 2015 · 10 citations · Full text

Rows per page

1–4 of 4